Health Care & Life Sciences » Pharmaceuticals | FluoroPharma Medical Inc.

FluoroPharma Medical Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Cash & Short Term Investments
1,304.10
1,778.00
292.10
290.80
24.70
Other Current Assets
77.30
53.00
74.90
218.20
23.10
Total Current Assets
1,381.40
1,831.00
367.00
509.00
47.80
Net Property, Plant & Equipment
176.90
35.40
11.70
11.00
7.40
Intangible Assets
55.20
49.30
357.50
318.50
279.60
Other Assets
-
-
83.90
-
-
Total Assets
1,613.50
1,915.70
820.20
838.60
334.80
ST Debt & Current Portion LT Debt
-
-
2,123.40
4,349.40
5,824.60
Accounts Payable
137.80
183.30
1,064.50
-
-
Other Current Liabilities
97.70
2,788.90
2,428.90
4,349.50
4,689.50
Total Current Liabilities
235.50
2,972.20
5,616.80
8,699.00
10,514.10
Total Liabilities
235.50
2,972.20
5,616.80
8,699.00
10,514.10
Common Equity (Total)
1,375.90
1,064.50
4,803.30
7,865.90
10,184.70
Total Shareholders' Equity
1,378.00
1,056.40
4,796.60
7,860.40
10,179.30
Total Equity
1,378.00
1,056.40
4,796.60
7,860.40
10,179.30
Liabilities & Shareholders' Equity
1,613.50
1,915.70
820.20
838.60
334.80
Preferred Stock (Carrying Value)
2.10
8.10
6.60
5.50
5.40

About FluoroPharma Medical

View Profile
Address
8 Hillside Avenue
Montclair New Jersey 07042
United States
Employees -
Website http://www.fluoropharma.com
Updated 07/08/2019
FluoroPharma Medical, Inc. engages in the research, development, and commercialization molecular imaging pharmaceuticals with initial applications in the area of cardiology. It focuses on the development of breakthrough positron emission tomography imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ.